Steven Rosenberg

4.9k total citations · 2 hit papers
49 papers, 4.1k citations indexed

About

Steven Rosenberg is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Steven Rosenberg has authored 49 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Cancer Research and 9 papers in Organic Chemistry. Recurrent topics in Steven Rosenberg's work include Protease and Inhibitor Mechanisms (16 papers), Cell Adhesion Molecules Research (9 papers) and Peptidase Inhibition and Analysis (7 papers). Steven Rosenberg is often cited by papers focused on Protease and Inhibitor Mechanisms (16 papers), Cell Adhesion Molecules Research (9 papers) and Peptidase Inhibition and Analysis (7 papers). Steven Rosenberg collaborates with scholars based in United States, Russia and United Kingdom. Steven Rosenberg's co-authors include Harold A. Chapman, Ying Wei, Michael Doyle, Daniel I. Simon, David Waltz, Sarah Bodary, Matvey Lukashev, Robert J. Drummond, Navin Rao and Jack F. Kirsch and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Steven Rosenberg

49 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of Integrin Function by the Urokinase Receptor

1996 654 citations Ying Wei, Daniel I. Simon et al. profile →
Identification of the urokinase receptor as an adhesion receptor for vitronectin.

1994 517 citations Ying Wei, David Waltz et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Steven Rosenberg

Since Specialization

Citations

This map shows the geographic impact of Steven Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Rosenberg more than expected).

Fields of papers citing papers by Steven Rosenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Rosenberg. The network helps show where Steven Rosenberg may publish in the future.

Co-authorship network of co-authors of Steven Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Rosenberg. A scholar is included among the top collaborators of Steven Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Rosenberg. Steven Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Species-specific urokinase receptor ligands reduce glioma growth and increase survival primarily by an antiangiogenesis mechanism 2004 ·Laboratory Investigation ·Xingyao Bu, Vazgen Khankaldyyan, Ignacio Gonzales-Gomez, Susan Groshen, Ye Wei, Shaoqiu Zhuo, Jaume Pons, Jennifer Stratton, Steven Rosenberg, Walter E. Laug	26
2	Preface The Urokinase-type Plasminogen Activator System in Cancer and other Pathological Conditions: Introduction and Perspective [Hot Topic: The Urokinase-type Plasminogen Activator System in Cancer (Executive Editor : S. Rosenberg)]. 2003 ·Current Pharmaceutical Design ·Steven Rosenberg	11
3	Random Peptide Bacteriophage Display as a Probe for Urokinase Receptor Ligands 2002 ·Biological Chemistry ·Susan Fong, Michael Doyle, Robert J. Goodson, Robert J. Drummond, Jennifer Stratton, (unknown), Laura V. Doyle, Harold A. Chapman, Steven Rosenberg	6
4	New developments in the urokinase-type plasminogen activator system 2001 ·Expert Opinion on Therapeutic Targets ·Steven Rosenberg	14
5	Recent advances in the molecular biology of hepatitis C virus 2001 ·Journal of Molecular Biology ·Steven Rosenberg	153
6	Identification of a Urokinase Receptor-Integrin Interaction Site 2000 ·Journal of Biological Chemistry ·Daniel I. Simon, Ying Wei, Li Zhang, (unknown), Hui Xu, Zhiping Chen, Qiumei Liu, Steven Rosenberg, Harold A. Chapman	175
7	Nonproteolytic Role for the Urokinase Receptor in Cellular Migration In Vivo 2000 ·American Journal of Respiratory Cell and Molecular Biology ·David Waltz, (unknown), (unknown), Lisa Natkin, Shaoqiu Zhuo, Craig Gérard, Steven Rosenberg, Harold A. Chapman	75
8	Semirational design of a potent, artificial agonist of fibroblast growth factor receptors 1999 ·Nature Biotechnology ·Marcus Ballinger, Venkatakrishna Shyamala, (unknown), (unknown), Laura V. Doyle, Jianxin Wang, (unknown), Jennifer Stratton, Gerald Apell, Jill Winter, Michael Doyle, Steven Rosenberg, W. Michael Kavanaugh	56
9	Receptor-independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice 1998 ·The Journal of Cell Biology ·Peter Carmeliet, Lieve Moons, Mieke Dewerchin, Steven Rosenberg, Jean‐Marc Herbert, Florea Lupu, Désiré Collen	109
10	Requirement of Receptor-bound Urokinase-type Plasminogen Activator for Integrin αvβ5-directed Cell Migration 1996 ·Journal of Biological Chemistry ·Mayra Yebra, Graham C. Parry, Staffan Strömblad, Nigel Mackman, Steven Rosenberg, Barbara M. Mueller, David A. Cheresh	217
11	Yeast expression and phagemid display of the human urokinase plasminogen activator epidermal growth factor-like domain 1995 ·Protein Engineering Design and Selection ·Jennifer R. Stratton-Thomas, H Y Min, Susan Kaufman, (unknown), Guy T. Mullenbach, Steven Rosenberg	19
12	Application of tritium high resolution NMR spectroscopy to analysis of tritium-labelled amino acids and peptides 1992 ·Amino Acids ·Steven Rosenberg, Yu. A. Zolotarev, (unknown)	11
13	Expression and characterization of recombinant hepatitis A virus 3C proteinase 1992 ·Biochemistry ·Bruce A. Malcolm, Sherman M. Chin, David A. Jewell, Jennifer R. Stratton-Thomas, Kent Thudium, Robert Ralston, Steven Rosenberg	50
14	The synthesis of tritium‐labelled alanine by solid‐state catalytic reactions 1992 ·Journal of Labelled Compounds and Radiopharmaceuticals ·(unknown), (unknown), (unknown), (unknown), Steven Rosenberg, N. F. Myasoedov	4
15	Synthesis and heteronuclear NMR analysis of deuterium- and tritium-labelled methylenebisphosphonic acid 1992 ·Tetrahedron Letters ·G. Michael Blackburn, Steven Rosenberg, (unknown)	2
16	Solid‐phase catalytic isotope exchange of alkylxanthines with gaseous tritium 1992 ·Journal of Labelled Compounds and Radiopharmaceuticals ·(unknown), (unknown), (unknown), Steven Rosenberg	1
17	Fermentation of a Yeast Producing A. Niger Glucose Oxidase: Scale-Up, Purification and Characterization of the Recombinant Enzyme 1991 ·Nature Biotechnology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laura De Clerck, (unknown), Steven Rosenberg	33
18	[28] Glyceraldehyde-3-phosphate dehydrogenase-derived expression cassettes for constitutive synthesis of heterologous proteins 1990 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Steven Rosenberg, Doris Coit, Patricia Tekamp-Olson	26
19	Characterization of antithrombins produced by active site mutagenesis of human alpha 1-antitrypsin expressed in yeast 1989 ·Blood ·(unknown), Philip A. Pemberton, (unknown), (unknown), (unknown), Steven Rosenberg, (unknown), (unknown)	12
20	Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor. 1985 ·Journal of Biological Chemistry ·James Travis, Maurice C. Owen, P.M. George, R.W. Carrell, Steven Rosenberg, (unknown), (unknown)	121

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact